We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTC icon
2451
PUT
Intel
INTC
$466B
$3.1K ﹤0.01%
+100
New +$3.28K
MACK
2452
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.15K ﹤0.01%
+38,221
New +$567K
VCXB.WS
2453
CALL
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$404 ﹤0.01%
40,436
AAXJ icon
2454
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
-19,284
Closed -$1.31M
ABEO icon
2455
Abeona Therapeutics
ABEO
$345M
-128,903
Closed -$935K
ABOS icon
2456
Acumen Pharmaceuticals
ABOS
$154M
-89,707
Closed -$363K
ABR icon
2457
Arbor Realty Trust
ABR
$960M
-783,300
Closed -$10.4M
ABT icon
2458
CALL
Abbott
ABT
$180B
-22,000
Closed -$2.29M
ACIW icon
2459
ACI Worldwide
ACIW
$5.72B
-51,779
Closed -$1.72M
ACLX
2460
DELISTED
Arcellx
ACLX
-3,300
Closed -$230K
ACM icon
2461
Aecom
ACM
$9.07B
-112,466
Closed -$11M
ACT icon
2462
Enact Holdings
ACT
$6.53B
-61,046
Closed -$1.9M
ADCT icon
2463
ADC Therapeutics
ADCT
$146M
-243,243
Closed -$1.09M
ADNT icon
2464
Adient
ADNT
$1.6B
-256,184
Closed -$8.43M
ADP icon
2465
CALL
Automatic Data Processing
ADP
$100B
-122,300
Closed -$30M
ADP icon
2466
PUT
Automatic Data Processing
ADP
$100B
-86,000
Closed -$21.1M
ADUS icon
2467
Addus HomeCare
ADUS
$2.14B
-10,068
Closed -$1.04M
AERT
2468
Aeries Technology
AERT
$37.7M
-2,588
Closed -$52.8K
AFL icon
2469
Aflac
AFL
$63.9B
-4,728
Closed -$406K
AGCO icon
2470
AGCO
AGCO
$8.78B
-44,846
Closed -$5.52M
AGL icon
2471
Agilon Health
AGL
$1.64B
-9,119
Closed -$1.39M
AKRO
2472
DELISTED
Akero Therapeutics
AKRO
-120,674
Closed -$3.05M
AKYA
2473
DELISTED
Akoya BioSciences
AKYA
-22,017
Closed -$103K
ALE
2474
DELISTED
Allete
ALE
-34,235
Closed -$2.04M
ALEX
2475
DELISTED
Alexander & Baldwin
ALEX
-14,194
Closed -$234K

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.